-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
EVgo
- The Trade: EVgo, Inc. (NASDAQ:EVGO) Director David Nanus acquired a total 5,882,352 shares an average price of $4.25. To acquire these shares, it cost around $25 million.
- What's Happening: EVgo announced pricing of an offering of Class A common stock.
- What EVgo Does: EVgo owns and operates a public direct current fast charging network in the U.S. EVgo's network of charging stations provides electric vehicle charging infrastructure to consumers and businesses.
HCW Biologics
- The Trade: HCW Biologics Inc. (NASDAQ:HCWB) CFO Rebecca Byam acquired a total of 58,486 shares at an average price of $1.56. The insider spent around $91.08 thousand to buy those shares.
- What's Happening: HCW Biologics posted in-line loss for its first quarter.
- What HCW Biologics Does: HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases.
-
Bioventus
- The Trade: Bioventus Inc. (NASDAQ:BVS) Interim CEO Anthony Bihl III acquired a total of 125,000 shares at an average price of $2.33. To acquire these shares, it cost around $290.99 thousand.
- What's Happening: Bioventus posted better-than-expected quarterly sales.
- What Bioventus Does: Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process.
Check This Out: Top 5 Industrials Stocks That May Collapse In May
Don't forget to check out our premarket coverage here
The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週三收盤下跌超過250點。當內部人士購買或出售股票時,這表明他們對公司前景的信心或擔憂。對便士股感興趣的投資者和交易者可以將其視爲其整體投資或交易決策中的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的細價股內幕交易。欲瞭解更多,請查看 本辛加的內幕交易 平臺。
EVgo
evGo
- The Trade: EVgo, Inc. (NASDAQ:EVGO) Director David Nanus acquired a total 5,882,352 shares an average price of $4.25. To acquire these shares, it cost around $25 million.
- What's Happening: EVgo announced pricing of an offering of Class A common stock.
- What EVgo Does: EVgo owns and operates a public direct current fast charging network in the U.S. EVgo's network of charging stations provides electric vehicle charging infrastructure to consumers and businesses.
- 交易: evGo, Inc. (納斯達克股票代碼:EVGO)董事戴維·納納斯 共收購了 5,882,352 股股票 平均價格爲4.25美元。收購這些股票的成本約爲2500萬美元。
- 發生了甚麼: EvGo宣佈了A類普通股發行的定價。
- evgo 會做甚麼: evGo 在美國擁有並運營公共直流快速充電網絡。evGo 的充電站網絡爲消費者和企業提供電動汽車充電基礎設施。
HCW Biologics
HCW Biologics
- The Trade: HCW Biologics Inc. (NASDAQ:HCWB) CFO Rebecca Byam acquired a total of 58,486 shares at an average price of $1.56. The insider spent around $91.08 thousand to buy those shares.
- What's Happening: HCW Biologics posted in-line loss for its first quarter.
- What HCW Biologics Does: HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases.
-
Bioventus
- The Trade: Bioventus Inc. (NASDAQ:BVS) Interim CEO Anthony Bihl III acquired a total of 125,000 shares at an average price of $2.33. To acquire these shares, it cost around $290.99 thousand.
- What's Happening: Bioventus posted better-than-expected quarterly sales.
- What Bioventus Does: Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process.
- 這筆交易: HCW Biologics Inc. (納斯達克股票代碼:HCWB)首席財務官麗貝卡·拜亞姆 共收購了58,486股股票 平均價格爲1.56美元。內部人士花費了約91.08萬美元購買這些股票。
- 發生了甚麼:HCW Biologics公佈了第一季度的在線虧損。
- HCW Biologics 是做甚麼的: HCW Biologics Inc是一家處於臨床階段的生物製藥公司,專注於發現和開發新的免疫療法,通過打破慢性、低度炎症與年齡相關疾病之間的聯繫來延長健康壽命。
-
生物文圖斯
- 這筆交易: Bioventus Inc. (納斯達克股票代碼:BVS)臨時首席執行官安東尼·比爾三世 共收購了12.5萬股股票 平均價格爲2.33美元。收購這些股票的成本約爲290.99萬美元。
- 發生了甚麼:Bioventus公佈的季度銷售額好於預期。
- Bioventus 在做甚麼: Bioventus Inc是一家醫療技術公司。該公司正在開發和商業化臨床差異化療法,這些療法涉及和增強人體的自然癒合過程。
Check This Out: Top 5 Industrials Stocks That May Collapse In May
看看這個: 五月份可能暴跌的五大工業股
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧